Abbott’s nutritional products business has China in its rearview mirror as a pediatric market, progress on restoring infant formula manufacturing capacity, nearly 4% sales growth in its latest quarter and signs of tailwinds ahead.
The firm on 19 April reported 3.8% first-quarter growth in total nutritional sales to $1.97bn, driven by 19.9% growth in...








